Cargando…
Roads to the development of improved pertussis vaccines paved by immunology
Current acellular pertussis vaccines have various shortcomings, which may contribute to their suboptimal efficacy and waning immunity in vaccinated populations. This calls for the development of new pertussis vaccines capable of inducing long-lived protective immunity. Immunization with whole cell p...
Autores principales: | Brummelman, Jolanda, Wilk, Mieszko M., Han, Wanda G.H., van Els, Cécile A.C.M., Mills, Kingston H.G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626578/ https://www.ncbi.nlm.nih.gov/pubmed/26347400 http://dx.doi.org/10.1093/femspd/ftv067 |
Ejemplares similares
-
Immunization with whole cell but not acellular pertussis vaccines primes CD4 T(RM) cells that sustain protective immunity against nasal colonization with Bordetella pertussis
por: Wilk, Mieszko M., et al.
Publicado: (2019) -
Immunological Signatures after Bordetella pertussis Infection Demonstrate Importance of Pulmonary Innate Immune Cells
por: Raeven, René H. M., et al.
Publicado: (2016) -
Azithromycin Clears Bordetella pertussis Infection in Mice but Also Modulates Innate and Adaptive Immune Responses and T Cell Memory
por: Borkner, Lisa, et al.
Publicado: (2018) -
Next-Generation Pertussis Vaccines Based on the Induction of Protective T Cells in the Respiratory Tract
por: Chasaide, Caitlín Ní, et al.
Publicado: (2020) -
A Pertussis Outer Membrane Vesicle-Based Vaccine Induces Lung-Resident Memory CD4 T Cells and Protection Against Bordetella pertussis, Including Pertactin Deficient Strains
por: Zurita, María Eugenia, et al.
Publicado: (2019)